Log In
Print
BCIQ
Print
Print this Print this
 

VIS410

  Manage Alerts
Collapse Summary General Information
Company Visterra Inc.
DescriptionBroad-spectrum mAb against a conserved influenza A virus hemagglutinin (HA)
Molecular Target Influenza A virus hemagglutinin
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsTreat and prevent influenza A virus infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today